Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ? | Drugs
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation | Nature Reviews Cardiology
Medicina | Free Full-Text | Aspirin Is Related to Worse Clinical Outcomes of COVID-19
Pre-hospital Aspirin Use and Patient Outcomes in COVID-19: Results from the International Viral Infection and Respiratory Illness Universal Study (VIRUS) | Archivos de Bronconeumología
Neurology International | Free Full-Text | Ischemic Stroke and SARS-CoV-2 Infection: The Bidirectional Pathology and Risk Morbidities
Aspirin & COVID-19 | The International Aspirin Foundation
Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents - The Lancet Infectious Diseases
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry | Heart
Effectiveness of a multidrug therapy consisting of Ivermectin, Azithromycin, Montelukast, and Acetylsalicylic acid to prevent hospitalization and death among ambulatory COVID-19 cases in Tlaxcala, Mexico - International Journal of Infectious Diseases
Full article: Low-dose aspirin for early COVID-19: does the early bird catch the worm?
Use of non-steroidal anti-inflammatory drugs and adverse outcomes during the COVID-19 pandemic: A systematic review and meta-analysis - eClinicalMedicine
Therapeutic advances in COVID-19 | Nature Reviews Nephrology
Could Low Doses Acetylsalicylic Acid Prevent Thrombotic Complications in COVID-19 Patients? - Federico Cacciapuoti, Fulvio Cacciapuoti, 2021
COVID-19 therapeutics: Challenges and directions for the future | PNAS
Frontiers | Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation
Frontiers | Aspirin in COVID-19: Pros and Cons
Aspirin Use is Associated with Decreased Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis
To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial - British Journal of Anaesthesia
Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia - The Lancet Respiratory Medicine
Aspirin may reduce risk of severe COVID symptoms: Study
Association of mortality and aspirin use for COVID-19 residents at VA Community Living Center Nursing Homes | medRxiv
Frontiers | Aspirin in COVID-19: Pros and Cons
Aspirin | C9H8O4 | CID 2244 - PubChem
Could aspirin intake reduce mortality risk in COVID-19 patients?
Post-acute COVID-19 syndrome | Nature Medicine
Rationales and uncertainties for aspirin use in COVID-19: a narrative review | Family Medicine and Community Health
